SCM
BIOA

Silverarc Capital Management’s BioAge Labs BIOA Stock Holding History

Silverarc Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-39,974
Closed -$231K – 83
2024
Q4 		$231K Sell
39,974
-60,026
-60% -$1.04M 0.05% 60
2024
Q3 		$2.08M Buy
+100,000
New +$2M 0.47% 49

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Silverarc Capital Management's BIOA Position: Q1 2025 in Review

Silverarc Capital Management sold out of BioAge Labs (BIOA) in Q1 2025, closing a stake of 39,974 shares — an estimated $231K sold.

Silverarc Capital Management first reported a position in BIOA in Q3 2024 and held it in 2 quarters. The position peaked at $2.08M in Q3 2024. 67 funds tracked by Wall St. Rank hold BIOA as of Q1 2025.

  • Silverarc Capital Management reported no remaining BioAge Labs position as of Q1 2025 after selling out during the quarter.
  • Silverarc Capital Management sold 39,974 BioAge Labs shares in Q1 2025, an estimated $231K.
  • Silverarc Capital Management first reported a position in BioAge Labs in Q3 2024 and held it in 2 quarters.
  • Silverarc Capital Management's BioAge Labs position peaked at $2.08M in Q3 2024.
  • 67 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2025.

Based on Silverarc Capital Management's 13F filing for Q1 2025, filed 14 May 2025.